|
Phase 1b study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced melanoma (KEYNOTE-041) |
|
|
|
Titel: |
Phase 1b study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced melanoma (KEYNOTE-041) |
Auteur: |
Yamazaki, Naoya Takenouchi, Tatsuya Fujimoto, Manabu Ihn, Hironobu Uchi, Hiroshi Inozume, Takashi Kiyohara, Yoshio Uhara, Hisashi Nakagawa, Kazuhiko Furukawa, Hiroshi Wada, Hidefumi Noguchi, Kazuo Shimamoto, Takashi Yokota, Kenji |
Verschenen in: |
Cancer, chemotherapy and pharmacology |
Paginering: |
Jaargang 79 (2017) nr. 4 pagina's 651-660 |
Jaar: |
2017 |
Inhoud: |
|
Uitgever: |
Springer Berlin Heidelberg, Berlin/Heidelberg |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|